Overview
The primary purpose of this study is to compare the therapeutic efficacy of intrauterine device and uterine artery embolization for uterine adenomyosis.
Description
Screening
- History, Physical examination
- Laboratory test (Hemoglobin) / MRI
- Pictorial blood loss assessment chart
- Symptom/Quality of life score
Intervention
- Intrauterine device or uterine artery embolization
- Adverse event montoring
Follow-up visit #1 (1 month)
- Vital signs
- blood test (Hemoglobin) / Ultrasound
- Adverse event monitoring
Follow-up visit #2 (3 month)
• MRI only for embolization patients
Follow-up visit #3 (6 months)
- Blood test (Hemoglobin) / Ultrasound
- Pictorial blood loss assessment chart
- Symptom/Quality of life score
Follow-up visit #4 (12months)
- Blood test (Hemoglobin) / Ultrasound
- Pictorial blood loss assessment chart
- Symptom/Quality of life score
Eligibility
Inclusion Criteria:
- Women with symptomatic fibroids (age: 19 - 48 years old) 2. Hemglobin < 12g/dL, 3. Symptoms of adenomysis (Menorrhagia, Dysmenorrhea)
Exclusion Criteria:
- Gynecologic malignancy 2. Ongoing infection or inflammation 3. Coagulopathy (platelet < 50,000 or INR > 1.5) 4. Concomitant endometriosis 5. Pregnancy